Canadian executives are not entirely optimistic about vaccines decreasing the spread of COVID
TORONTO, February 15, 2021
In the latest survey from The Business Monitor, released by Modus Research, Canadian managers and executives were asked about the likelihood of the vaccines effectively decreasing the spread of COVID and about the likelihood of the pandemic worsening before a vaccine is fully rolled out in Canada.
While executives are not pessimistic about the vaccines’ effectiveness, fewer than a majority are strongly convinced that they will be effective in decreasing the spread of COVID in Canada. Also, the vast majority of managers and executives think it is at least somewhat likely that the pandemic will worsen before a vaccine is fully rolled out in Canada.
This survey was carried out among a representative sample of over 700 Canadian managers and executives at the end of 2020. Unlike other business surveys, the sample is fully random and representative of all Canadian businesses.
As we have seen since the start of COVID, Quebec businesses are the least pessimistic about the pandemic. Managers and executives in Quebec are much less likely than their counterparts in Ontario and elsewhere to believe that the pandemic will worsen before a vaccine is fully rolled out.
About The Business Monitor
The Business Monitor is Canada’s only B2B omnibus service. Results from the Monitor are based on scientific samples of Canadian business leaders.
About Modus Research
Established in 2012, Modus Research is a full-service research agency that provides clients with actionable feedback from Canadian enterprises based on scientifically representative samples. We offer our clients exclusive access to the Modus Business Panel – the gold standard of B2B research in Canada.
For more information on this release or The Business Monitor please contact:
Charlie Graves
President, Modus Research
Phone: 1-800-254-6944 x224
Email: cgraves at modusresearch dot com
Twitter: @ModusResearch
